Skip to Content
  • Compassion, Drug Prices, and Money

    A number of people have sent along this article from The Guardian. It’s about Jamie Love, a campaigner for cheaper pharmaceuticals. It’s a long, wel… Read More
  • The Management Hat

    On this anniversary, I wanted to point back to an older post here: Roger Boisjoly and the Management Hat. He tried, repeatedly, to keep the Challenger disaster… Read More
  • Arguing About Zafgen’s Chances

    It’s been a wild ride for Zafgen and those following the company, and things are nowhere near over. Back in December, it became clear that two patients ha… Read More
  • Mannkind’s Last Stand

    Back in October, I said that Mannkind (MNKD) “looks doomed”. To be honest, you could have said that about them and their inhaled-insulin drug Afrezz… Read More
  • Pfizer Versus BMS, Since 1989

    I very much enjoyed this piece by Bernard Munos on Pfizer. It follows the same method as this classic article by Matthew Herper (updated here, commented on here… Read More
  • The Details of Shkreli’s Fraud

    If you want to know all the details of why Martin Shkreli was indicted, and how he has become associated with securities fraud (instead of just being associated… Read More
  • Drug Costs, Real and Fake

    Here’s an interesting look at the price of a single orphan medication: the rattlesnake antivenom CroFab, which has already been held up as an example of … Read More
Page 10 of 103« First...89101112...203040...Last »